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Background: Swine influenza is a highly contagious viral infection in pigs affecting the respiratory tract that can
have significant economic impacts. Streptococcus suis serotype 2 is one of the most important post-weaning bacterial
pathogens in swine causing different infections, including pneumonia. Both pathogens are important contributors to
the porcine respiratory disease complex. Outbreaks of swine influenza virus with a significant level of co-infections due
to S. suis have lately been reported. In order to analyze, for the first time, the transcriptional host response of swine
tracheal epithelial (NPTr) cells to H1N1 swine influenza virus (swH1N1) infection, S. suis serotype 2 infection and a
dual infection, we carried out a comprehensive gene expression profiling using a microarray approach.
Results: Gene clustering showed that the swH1N1 and swH1N1/S. suis infections modified the expression of
genes in a similar manner. Additionally, infection of NPTr cells by S. suis alone resulted in fewer differentially expressed
genes compared to mock-infected cells. However, some important genes coding for inflammatory mediators such as
chemokines, interleukins, cell adhesion molecules, and eicosanoids were significantly upregulated in the presence of
both pathogens compared to infection with each pathogen individually. This synergy may be the consequence,
at least in part, of an increased bacterial adhesion/invasion of epithelial cells previously infected by swH1N1, as
recently reported.
Conclusion: Influenza virus would replicate in the respiratory epithelium and induce an inflammatory infiltrate
comprised of mononuclear cells and neutrophils. In a co-infection situation, although these cells would be unable
to phagocyte and kill S. suis, they are highly activated by this pathogen. S. suis is not considered a primary pulmonary
pathogen, but an exacerbated production of proinflammatory mediators during a co-infection with influenza virus may
be important in the pathogenesis and clinical outcome of S. suis-induced respiratory diseases.
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Streptococcus suis is one of the most important post-
weaning bacterial pathogens in swine causing mainly
septicemia with or without sudden death, meningitis,
arthritis and endocarditis. It is also considered an agent
of pneumonia, although its role as primary or secondary
respiratory pathogen has been controversial [1]. Over
the last few years, this pathogen has been considered
an emerging zoonotic agent [2]. Human infections with
S. suis manifest mainly as meningitis, septicemia and
septic shock [3]. Among the described S. suis serotypes,
type 2 is usually considered as the most virulent for both
pigs and humans in most countries [2]. Pigs usually
acquire S. suis via the respiratory route [1]. In fact,
colonization of the nasopharyngeal cavity is an import-
ant risk factor for S. suis infection of piglets. Some colo-
nized animals may never develop disease (carrier
animals); on the other hand, some carrier piglets will
eventually develop bacteremia, with dissemination in the
bloodstream followed by septicemia [1]. It is believed
that humans can become infected through skin lesions,
surface mucosa and/or the oral route following the
ingestion of contaminated pork products [4]. Tonsil car-
riage of S. suis by humans without clinical signs (usually
slaughterhouse workers) has also been described [5,6].
Although there is evidence suggesting that the naso-
pharynx and palatine tonsils may be the routes of entry
in swine invasive diseases [7], it is still unknown how
virulent serotype 2 strains of S. suis manage to cross the
first natural line of the host defense to initiate disease. It
has been suggested that the pathogen would breach the
mucosal epithelium in the upper respiratory tract, locally
contributing to respiratory pathology and/or further in-
vading the bloodstream [8]. Limited data are available
concerning the interaction between S. suis and swine
respiratory epithelial cells. Ferrando and colleagues [9]
described S. suis adhesion (but not invasion) to porcine
tracheal epithelial cells. More specifically, bacterial adher-
ence was 20-fold stronger than that previously reported
with the human laryngeal carcinoma cell line HEp-2.
Swine influenza is a highly contagious viral infection
in pigs affecting the respiratory tract that can have sig-
nificant economic impacts [10]. Although this infection
is typically self-limited with high-morbidity but low mor-
tality, secondary complications substantially increase
illness and death [11]. In fact, swine influenza virus is a
key contributor to the porcine respiratory disease com-
plex (PRDC), a multifactorial syndrome characterized by
severe respiratory disease after infection with two or
more infectious agents. Both S. suis and swine influenza
virus are part of the PRDC. Outbreaks of swine influ-
enza virus with a significant level of co-infections
with S. suis have been lately reported in England [12].
More recently, we have shown an increased adhesion/invasion of S. suis serotype 2 in influenza pre-infected
tracheal epithelial cells [13]. Preliminary studies sug-
gested increased activation of co-infected tracheal epi-
thelial cells [13].
No data were available so far concerning a complete
transcriptional response of swine epithelial cells to swine
influenza virus infection, S. suis infection and a dual in-
fection. Therefore, we carried out a comprehensive gene
expression profiling of H1N1 virus infection, S. suis
serotype 2 bacterial infection and dual virus-bacterial
infection of swine tracheal epithelial cells using a micro-
array approach. Results showed that cells are highly
activated after 24 h incubation with influenza virus and,
to a lesser extent, after 12 h incubation with S. suis.
However, bacterial infection of previously virus-infected
cells showed a clear synergy with an increased ex-
pression of certain inflammatory-related genes. An in-
creased inflammation in the lungs in the presence of
both pathogens may lead to a more serious respiratory
disease syndrome in pigs and may explain, at least in
part, the contribution of S. suis to pneumonia as a
secondary pathogen.
Results
Transcriptional response of tracheal epithelial cells
infected by swine influenza virus, S. suis or both
pathogens
To analyze the early transcriptional response following
infection with S. suis of swine influenza virus-infected or
non-infected porcine tracheal epithelial cells, an Agilent
porcine microarray assay was carried out. Cells were also
analyzed in the presence of the virus only. In co-infected
experiments, cells were pre-infected with a H1N1 strain
of swine influenza virus for 12 h and then further incu-
bated for 12 h with a virulent strain of S. suis serotype 2.
Virus replication in these epithelial cells was observed
during the first 12 h of incubation, reaching a plateau
that lasted for the following 12 h [13]. Cells infected
with virus alone, bacteria alone, or co-infected with both
pathogens did not present any significant levels of cyto-
toxicity (lower than 5%, data not shown).
Data from activated cells were compared to mock-
infected cells. Using an expression threshold ≥ 2 fold with
a p < 0.05, a total of 588, 96 and 673 transcripts were
modified by the swH1N1 alone, S. suis alone, or both
pathogens in co-infection, respectively. Of them, some
upregulated and downregulated genes were shared by
the two pathogens (Figures 1A and B). The complete list
of genes is shown in Additional file 1: Tables S1 and S2.
These genes were widespread within different biologic
functional categories (Figure 2). Particularly, and other
than genes related to biological and metabolism pro-
cesses, genes associated with immune and inflammatory
response were highly overexpressed among upregulated
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Figure 1 Host genes are modified in greater numbers in NPTr cells co-infected by S. suis and swine influenza virus. Venn diagram
showing the total numbers of upregulated (A) or downregulated (B) genes in NPTr cells (n = 4 replicates per group) infected with S. suis, H1N1,
or co-infected with S. suis/H1N1 when compared to mock-infected cells, as determined by Agilent microarray study. Differentially expressed genes
were defined by fold changes greater than 2-folds (upregulation or downregulation) with an accompanying p-value≤ 0.05.
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roles not only in host defense but also in pathology (in-
flammation). It was clear that a pre-infection with
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Figure 2 Distribution and functional categories of genes differentially
downregulated (B) genes into different biologic functional categories from
when compared to mock-infected cells, as determined by Agilent microarrpreviously infected with the virus (Additional file 1:
Tables S1 and S2).
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expressed genes was performed (Figure 3A). Clustering
of the genes showed that infection with swH1N1 alone
and with both pathogens (swH1N1/S. suis) highly modi-
fied the expression of genes. Additionally, infection of
NPTr cells by S. suis resulted, after 12 h of incubation,
in a lower but still significant levels of expressed genes
compared to mock-infected cells. A few groups of genesH1N1S. suisMock S. suis/
H1N1
A
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Figure 3 Heat map of hierarchical clustering analysis of differentially
expressed were subjected to hierarchical clustering (complete linkage meth
rows represent individual genes and vertical columns represent individual sam
genes are zoomed in from the heat map in A. Color scale: black, average
high expression levels, respectively.were upregulated similarly in cells infected by S. suis
alone or in co-infected cells without any impact result-
ing from virus infection.
Interesting genes that were significantly upregulated
are zoomed in (Figure 3B) to better analyze their expres-
sion pattern in differently infected NPTr epithelial cells.
For example, results showed that swH1N1 infection sig-
nificantly increased the expression of the chemokinesH1N1S. suisMock S. suis/
H1N1
B
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and CXCL10 (IP-10) (Additional file 1: Table S1). In the
case of the monocyte chemoattractants CCL2, CCL4
and CCL5, their mRNA expression increase was particu-
larly important. Of these three genes, only CCL5 was
significantly up-regulated (to a much lesser extent when
compared to swH1N1 infection) by S. suis alone. Simi-
larly, the proinflammatory cytokines IL-1α and IL-6
were mainly up-regulated by the swH1N1 infection. In
addition, genes related to cell adhesion and migration,
such as the β1 integrin vascular cell adhesion molecule 1
(VCAM-1), were also up-regulated by virus infection.
An important lipid metabolic mediator, cyclooxygenase
(COX)-2 mRNA, was up-regulated by virus alone and
both pathogens together. Plasminogen activator urokin-
ase (PLAU), a protease involved in degradation of the
extracellular matrix, was upregulated by virus infection
and coinfection with S. suis increased this upregulation
(Additional file 1: Table S1).
As expected, swH1N1 infection alone only clearly up-
regulated genes coding for interferon and interferon-
regulatory factors. More precisely, type I interferons (IFN)
and, to a certain extent, type III IFN (IFNλ1) gene ex-
pression were increased (Additional file 1: Table S1). Of
the type I IFNs, IFNβ gene but not IFNα gene was
up-regulated. IFN-regulated/stimulated genes affected
by virus infection are presented in detail in Additional
file 1: Table S1.
Quantitative RT-PCR results
In order not only to validate microarray results but also
to further study some specific genes based on their po-
tential implication in immune and inflammatory re-
sponse processes, we carried out quantitative real-time
PCR (qPCR) on 13 different genes (Additional file 1:
Table S3). All tested genes presented a perfect correl-
ation with microarray results, with the exception of
TNF. This proinflammatory cytokine did not show any
significant difference by microarray, but its expression
was shown to be up-regulated for virus and co-infected
cells (Figure 4). A higher sensitivity of the qPCR assay
can explain this difference.
Results obtained with qPCR assay for IFN gene ex-
pression confirmed those obtained by microarray. As ex-
pected, virus infection was responsible for type I and III
IFN up-regulation. IFNβ was up-regulated to a much
greater extent than IFNλ1. On the other hand, qPCR re-
sults of genes coding for IL-1α, IL-6, IL-8 and VCAM-1
confirmed no activation by S. suis alone, an intermediate
upregulation by swH1N1 infection but a significant in-
crease when cells were co-infected with both pathogens
(Figure 4 and Additional file 1: Table S3). Interestingly, a
clear increased of IL-6 and IL-8 by S. suis was reported
in the literature using the same cells [13]. However, inthat study, a late bacterial incubation time was used
(24 h), whereas an early time response (12 h) was ana-
lyzed in the present study. The chemokine CCL5 was
upregulated by S. suis, but considerably more activated
by virus and co-infection, as suggested by microarray re-
sults. Microarray results obtained with PLAU and COX2
were also confirmed by qPCR with a very significant up-
regulation of both gene expressions in co-infected cells
(Figure 4 and Additional file 1: Table S1).
Discussion
Airway epithelial cells are the initial site of both influ-
enza virus and S. suis infections [1,14]. Interestingly, S.
suis is not considered a primary cause of swine pneumo-
nia, but rather a secondary respiratory pathogen that
would complicate viral infections [1]. In a recent study,
tracheal cells pre-infected with swH1N1 showed a sig-
nificant increase of S. suis adhesion and invasion levels
when compared to normal cells. In fact, it was shown
that the bacterial capsular sialic acid moiety was respon-
sible for the increased binding of S. suis to the influenza
virus hemagglutinin protein expressed on the surface
of virus-infected cells [13]. A comprehensive host gene
expression profile of these cells infected with either swine
influenza virus, S. suis, or both pathogens (co-infection)
has not been reported so far.
The innate immune response is the first line of defense
against influenza infection. Among innate responses,
types I (IFNα and IFNβ) and III (IFNλ) IFN induction
and signaling are potent protection mechanisms against
viral infections [15]. Type III IFNs and IFNβ, which con-
tains similar promoter elements, are known to be the
first IFNs upregulated in response to pattern recognition
receptor signaling, while IFNα gene expression is driven
as part of IFN signaling amplification [16]. Both IFNβ
and, to a lesser extent, IFNλ1 were significantly induced
by swH1N1 virus only. As previously described [15], no
clear upregulation of IFNα was observed. In vivo, IFNα
is known to be an abundant and important cytokine
during influenza infection, but most often this finding is
linked to its expression in serum, probably produced by
plasmacytoid dendritic cells [17]. Interestingly, some
genes were downregulated in the presence of virus infec-
tion. Since it has been shown that non-structural (NS)
proteins of influenza may modulate and down-regulate
host-cellular processes, a certain role of such NS pro-
teins cannot be completely excluded [18].
Influenza virus infection at the respiratory tract site is
also characterized by an early influx of neutrophils
followed by an increased recruitment of blood derived
monocytes within the first days of infection. This influx
is driven by the release of chemokines from infected epi-
thelial cells and alveolar macrophages [19]. In the
present study, virus infection significantly increased the
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Figure 4 Proinflammatory cytokine and chemokine genes are highly expressed in NPTr epithelial cells infected by S. suis and swine
influenza virus. Expression of TNF, IFN-β, IFNλ1, IL-1, IL-6, IL-8, VCAM-1, CCL5, PLAU, and COX-2 genes in NPTr cells infected with S. suis, H1N1, or
S. suis/H1N1 when compared to mock-infected cells, as quantified by qPCR assay. Data represent mean relative expression values of mRNA ± SEM.
Groups that are significantly different are indicated by different letters (a, b, and c), as determined by One-way ANOVA with p≤ 0.05.
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http://www.biomedcentral.com/1746-6148/10/86expression of important chemokines in epithelial cells.
Of these genes, only CCL5 was induced by bacteria after
12 h of incubation in the absence of virus infection.
However, as it was the case for IL-6 and IL-8, CCL5
expression was clearly higher in co-infected cells, prob-
ably caused by an additive and/or synergistic effect due
to the simultaneous presence of both pathogens. Inter-
estingly, it has already been reported that S. suis is able
to induce the production of CCL5 in vivo and in vitro
from phagocytic and choroid epithelial cells [20,21]. In
addition, since an increased S. suis adhesion/invasion of
tracheal cells is observed in the presence of influenza
virus [13], the increased expression of some cytokines
may be the consequence of higher bacteria to cell ratio.
It has been reported that epithelial cells infected by
influenza virus elicit trans-epithelial recruitment of
monocytes mainly in a CCL2-dependent manner that is
primarily reliant on the engagement of VCAM-1 [19]. In
our study, expression of both CCL2 and VCAM-1 genes
was significantly increased after co-infection of swine
epithelial cells. Although we could not detect a clear
increase of VCAM-1 expression by S. suis infection
alone, a potential role of this pathogen in co-infected
cells cannot be ruled out. Expression of VCAM-1 gene
was shown in porcine choroid plexus epithelial cells acti-
vated by S. suis [22] and in different tissues after in vivo
infection [23]. In addition, it has been shown that S. suis
induces the upregulation of intercellular adhesion
molecule-1, CD11a/CD18, and CD11c/CD18 expres-
sion on human monocytes [24]. As mentioned, a
higher bacterial charge (in the presence of influenza
virus infection) [13] could also further activate epithe-
lial cells. The accumulation of large numbers of mono-
cytes within the lung parenchyma and alveolar spaces
has been described as a hallmark of early stages of in-
fluenza virus infection [10], and it may be amplified
when S. suis is also present. Recently, studies using
cultured human lung organ and bronchial/tracheal epi-
thelial cells showed that an influenza virus infection
induces considerable amount of CXCL10, a chemokine
that attracts activated natural killer and Th1 cells,
which have an essential role in virus infection clear-
ance [25]. Although we have previously reported that
S. suis induces the production of CXCL10 from den-
dritic cells [26], gene upregulation in tracheal cells
were only observed with swH1N1 infection in the
present study.
Eicosanoids are lipid mediators derived from arachi-
donic acid that play critical roles in the host response to
infection [27]. The cyclooxygenase enzymes (COX-1 and
COX-2), which catalyze the first step in the biosynthesis
of prostaglandins (PGs) from arachidonic acid, have spe-
cifically been implicated in host response to infection
[27]. One of the most important PGs is PGE2, which isknown to contribute to excessive inflammation. COX-1 is
generally believed to be constitutively expressed whereas
COX-2 is the inducible form [28]. COX-2 induction is
caused by a variety of stimuli, including bacteria and virus,
and it has been shown to play an important role in pneu-
monia as previously demonstrated for influenza and
Streptococcus pneumoniae infections [29-31]. In swine vet-
erinary infections, COX-2 plays an important role in lung
inflammation in animals experimentally infected with
Actinobacillus pleuropneumoniae [29]. Very little is known
about the activation of lipid metabolism by S. suis. There
was only one report showing that S. suis is able to induce
the secretion of PGE2 by human macrophages [32]. More
recently, we have shown that S. suis infection is accom-
panied by an increase of arachidonic acid, a proinflamma-
tory ω-6 polyunsaturated fatty acids (PUFA), and by a
decrease of docosahexaenoic acid, an anti-inflammatory
ω-3 PUFA. Macrophages infected with S. suis showed acti-
vation of mitogen-activated protein kinase pathways and
COX-2 increased expression [33]. In the present study,
the expression of COX-2 by tracheal epithelial cells in-
fected with both pathogens was 25 folds higher than that
observed with virus alone, indicating a synergistic effect of
S. suis on lipid metabolism. These data seem to indicate
that lipid mediators play an important role in S. suis sys-
temic disease as well as in influenza/S. suis co-infections
at the respiratory tract level.
Finally, virus induced the expression of PLAU. This in-
duction was significantly upregulated in the presence of
both pathogens and it can have important pathological con-
sequences. In fact, we have previously shown that S. suis
specifically binds porcine plasminogen on its surface [34].
Once bound, plasminogen can be converted into proteo-
lytically active plasmin by urokinase plasminogen activator
[34]. Plasmin-coated S. suis has been reported to induce
fibronectin degradation [34], a phenomenon that may con-
tribute to pathogen dissemination into tissues as well as to
the inflammatory process, given that certain fibronectin
fragments are known to be chemotactic for monocytes [35]
and can induce cytokine secretion by macrophages [36].
Finally, it is important to note that results obtained in
the present study were generated with a typical European
ST1 strain of S. suis. Serotype 2 strains present different
genotypic and phenotypic characteristics depending on
the geographical area [2]. Although strains from different
origins and different virulence properties have been shown
to similarly adhere and invade epithelial cells infected with
H1N1 virus [13], host cell activation using strains from
different geographical origins should be confirmed.
Conclusion
We carried out, for the first time, a comprehensive gene
expression profiling study using a microarray approach
on swine tracheal epithelial cells infected by either swine
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inflammatory genes (cytokines and chemokines) but also
those related to lipid metabolism playing a role in inflam-
mation were significantly upregulated during co-infection.
Upregulation of certain genes involved in bacterial patho-
genesis could also influence a higher virulence of S. suis
infection in the presence of influenza virus. It is important
to mention that these results were obtained from in vitro
assays and they should be confirmed with in vivo studies.
The observed synergistic effect may also be the conse-
quence, at least in part, of a higher S. suis adhesion to the
virus-hemagglutinin expressed by epithelial cells previ-
ously infected with swine influenza virus. In a co-infection
situation, influenza virus would replicate in the respiratory
epithelium inducing an inflammatory infiltrate comprised
of neutrophils and mononuclear cells. Despite that these
cells are unable to phagocyte and kill S. suis, they are
highly activated by this pathogen. S. suis is not considered
a primary pulmonary pathogen, but an exacerbated local
production of proinflammatory mediators during a
co-infection with influenza virus, as strongly suggested
by the results obtained in the present study, may be
important in the pathogenesis and clinical outcome of
S. suis associated respiratory infections.
Methods
Bacterial strains, epithelial cells and influenza virus strain
The well characterized S. suis strain 31533, which is a
highly virulent European strain isolated from a diseased
pig was used throughout this study [37,38]. This strain is
a serotype 2, sequence type 1 (as determined by multilo-
cus sequence typing), and well encapsulated under cul-
ture and assay conditions used in this study. Bacterial
growth conditions were performed as previously re-
ported, with some modifications [38]. Briefly, S. suis was
grown overnight on Todd-Hewitt agar (THA) (Becton
Dickinson, Mississauga, ON, Canada). Isolated colonies
were used as inoculum in 5 ml of Todd-Hewitt broth
(THB; Becton Dickinson) and incubated during 8 h at
37°C with agitation. Working bacterial cultures for epi-
thelial cells infections were produced by inoculating
10 μl of a 1000 fold serial dilution into 30 ml THB with
agitation at 37°C for 16 h. Bacteria were washed three
times in phosphate-buffered saline (PBS, pH 7.3) and ap-
propriately diluted in cell culture medium for the experi-
ments. The number of CFU/ml in the final suspension
was determined by plating samples onto THA using an
Autoplate® 4000 Automated Spiral Plater (Spiral Biotech,
Norwood, MA).
The pig tracheal epithelial cell line (NPTr) [39] was used
for virus growth and co-infection studies. NPTr cells were
grown in Minimum Essential Medium (MEM; Invitrogen,
Burlington, ON, Canada) supplemented with 10% (v/v)
heat-inactivated fetal bovine serum (FBS), penicillin-streptomycin (100 U/ml), gentamycin (0.04 mg/ml),
sodium pyruvate (1 mM), and L-glutamine (2 mM;
Invitrogen). Cells were cultured at 37°C with 5% CO2
in a humid atmosphere in T75 flasks or 24-well tissue
culture plates (Falcon; Becton Dickinson). For assays,
cells were treated with 0.05% trypsin in 0.03% EDTA
solution and diluted in culture medium to obtain a final
concentration of 105 cells/ml. Then, the cell suspension
was distributed into tissue culture plates and incubated
until cell confluence was reached. Twenty-four hours
before the assays, culture medium was removed from
the wells and replaced with fresh complete medium
without antibiotics.
Swine influenza virus H1N1 (swH1N1, strain A/swine/
St-Hyacinthe/148/1990) isolated from a case of swine flu
in Canada was also used for this study [40]. Virus was
propagated in NPTr cells as described [39]. Aliquots of
the supernatant containing infectious virions were stored
at −70°C. The titer of the produced viral stock was 107.25
TCID50/ml.
NPTr co-infection by swine influenza virus and S. suis
The methodology used was similar to the one recently
described [13]. There were 4 groups: a) non-infected
cells (24 h, control); b) cells infected with virus alone
(24 h); c) mock-infected cells (12 h) and then infected
with S. suis (12 h); and d) virus-infected cells (12 h) and
then infected with S. suis (co-infection). Four replicates
of independent experiments were done for microarray
analysis. The incubation time (12 h) for S. suis was chosen
to evaluate the early response, mainly in co-infected cells.
For the virus infected cells, swH1N1 (MOI:1) was inocu-
lated onto NPTr cell monolayers in 24-well culture plates
and incubated for 1 h with antibiotic free MEM at 37°C in
5% CO2. The virus-infected cells were then washed twice
with PBS and fresh media containing 10% FBS without
antibiotic was added and incubated for 12 h (for the co-
infected group) or 24 h for virus infected group. Infectious
viral load profile was determined by virus titration in cell
cultures and RT-PCR.
For the co-infected group, after a 12 h incubation at
37°C in 5% CO2 with virus, cells were further infected
with S. suis (106 CFU/well, MOI:10). Plates were cen-
trifuged at 800 × g for 10 min in order to bring bacteria
in close contact with the cells [41], and incubated at
37°C in 5% CO2 for 12 h. Similar bacterial treatment
was done to cells which were not previously infected
by virus (control). Low cell toxicity levels were con-
firmed using Cytotox 96 kit (Promega, Madison, WI)
from culture supernatants according to manufacturer’s
instructions. In parallel experiments, cells were either
mock-infected, infected with either virus or S. suis
alone following a similar methodology as described
above.
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RNA
At 12 h post-infection with S. suis, media was removed
and cells were washed once with PBS. Cells were then
treated with a lysis solution (RLT solution; Qiagen,
Valencia, CA) and total RNA from homogenized cells
was isolated and purified using RNeasy mini kit with
on-column DNase digestion according to manufacturer’s
protocol (Qiagen). Total RNA was kept at −80°C.
Agilent microarray analysis
The microarray experiment was performed at the McGill
University and Genome Québec Innovation Centre
(Montréal, Québec, Canada) using the Agilent porcine
(v2) gene expression microarray 4x44K (Agilent Tech-
nologies, Santa Clara, CA). Prior to the microarray ex-
periment, total RNA quality and quantity was assessed
using the Agilent 2100 Bioanalyzer (Agilent Technolo-
gies). The microarray was performed according to the
manufacturer’s instructions. Samples positions on chip
were randomly distributed.
Microarray data accession number
All microarray raw data are available and have been de-
posited in the Gene Omnibus Expression database under
accession numbers GSE52172.
Validation of microarray data by RT-qPCR
Thirteen genes were selected for the validation of micro-
array results by RT-qPCR (Table 1). The qPCR analysis
was executed to conform to the qPCR MIQE guidelines
[42]. The validation experiments were performed using
the same RNA samples that were used for the microarrayTable 1 Primer sequences used for real-time RT-qPCR
Gene Genebank ID Amplicon size Forward sequence (pr
Hipox NM_001032376 142 bp GCAGCCCCAGCGTCGTG
Ppia NM_214353 133 bp TGCAGACAAAGTTCCAA
Ccl5 NM_001129946 78 bp GAAATGGGTGCGGGAG
Cox2 NM_214321 165 bp TAGGATTCAGGGCTTTCA
Ifnβ NM_001003923 150 bp TGCAACCACCACAATTC
Il1a NM_214029 152 bp TGAAGATGGCCAAAGTC
Il6 NM_214399 105 bp ACTCCCTCTCCACAAGC
Il8 NM_213867 80 bp TGTGAGGCTGCAGTTCTG
Il12a NM_213993 162 bp CTGAAGGCCGTCAGCAA
Ifnλ1 NM_001142837 135 bp TGGCCTTAGAGGCTGAG
Irf1 NM_001097413 113 bp AATCCAGCCCTGATACC
Irf7 NM_001097428 94 bp CTGCGATGGCTGGATGA
Plau NM_213945 143 bp CTCCAAAGGCAGCCATG
Tnf NM_214022 112 bp GCCACCACGCTCTTCTG
Vcam1 NM_213891 126 bp TCCACGCTGGTCATGAAstudy and other supplemental samples. Extracted RNA
was converted into cDNA by reverse transcription of
500 ng total RNA using a Quantitect cDNA synthesis kit
(Qiagen). Then, qPCR assays were carried out using Sso-
Fast Evagreen Supermix kit (Bio-Rad, Hercules, CA) and
gene-specific primers (250 nM) on a CFX96 rapid thermal
cycler system (Bio-Rad). The cycling conditions were:
3 min of polymerase activation at 98°C followed by 40 cy-
cles at 98°C for 2 s and 57°C for 5 s. Melting curves were
generated after each run to confirm a single PCR product.
Primers (Integrated DNA technologies, Coralville, IA)
that were used for detection of genes were all verified to
have reaction efficiency between 90-110% (Table 1). The
GeNorm applet v.3.5 (http://medgen.ugent.be/~jvde-
somp/genorm/) was used to initially determine the two
most stable reference genes from a set of six reference
genes using random samples from the cDNA panel gen-
erated for the qPCR validation of the microarray. There-
fore, normalization of the data was done using the
reference genes Hypoxanthine (Hipox) and Peptidylpro-
lyl Isomerase A (Ppia).
Statistical analysis
Text files containing the signal and detection P-values
per probe for each sample were imported into FlexArray
software v.1.6.2 (McGill University and Genome Quebec
Innovation Centre; http://gqinnovationcenter.com/ser-
vices/bioinformatics/flexarray/index.aspx?l=e). Data were
first processed by analyzing box plot of intensity of sam-
ples to ensure that signal intensity data were comparable
between samples. Data were then processed by applying
a variance-stabilizing normalization (VSN) filter in order
to normalize the datasets. The VSN method fits the VSNimer #) Reverse sequence (primer #) Efficiency (qPCR)
ATT CGAGCAAGCCGTTCAGTCCTGT 99
AGACAG GCCACCAGTGCCATTATGG 97
TACA GTTTGCACGAGTTCAGGCTC 94
CTGGCT TGTCAGCCGACAATGAGATGTGGA 105
CAGAAGG TCTGCCCATCAAGTTCCACAAGGA 102
CCTGACCT ATCCATGCCGTCCCCAGGAAGTG 93
GCCTT TGGCATCTTCTTCCAGGCGTCCC 97
GCAAG GGGTGGAAAGGTGTGGAATGCGT 95
CAC AGCCAGGCAACTCTCATTCG 92
CTA CCCTGATGCAAGCCTGAAGT 91
TTCTCT GGCCTGTTCAATGTCCAAGTC 95
A TAAAGATGCGCGAGTCGGA 90
AAC CACAGTGCTCCCCTTGGAAT 106
CCTA ACGATGATCTGAGTCCTTGGGCCA 91
TCC TGGGTCCTTGGGGAAAGAGTA 101
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methods of preprocessing two-color microarray data,
VSN normalization is a one-step procedure. The data
are returned on a generalized logarithm scale to base 2.
A principal component of analysis plot was created to
observe separation of different treatment groups. No
outliers were removed from the data. Then, scatter plots
of expression were analyzed to ensure that probe data
within a treatment group were not differentially expressed
but also to verify that some probes were differentially
expressed between different treatment groups, indicating
possible differentially expressed genes. Afterward, an ana-
lysis of variance (ANOVA) was used to search for differen-
tially expressed genes between infected and mock-infected
group. ANOVA results were then post-processed in flexar-
ray by a FDR correction using a Benjamini Hochberg algo-
rithm. Differentially expressed genes were defined by fold
changes greater than 2-folds or smaller than 0.5 fold with
an accompanying P-value ≤ 0.05. Heat map was then con-
structed using Cluster 3.0 [43] and Java Tree view 1.1.6r4
[44]. Heat map construction of normalized expression of
differentially expressed genes was performed using hier-
archical cluster analysis with uncentered correlation used
as similarity metric and complete linkage as clustering
method.
For RT-qPCR analysis, fold-changes of gene expression
were calculated using CFX software manager v.3.0 (Bio-
Rad). Samples from mock-infected NPTr cells were used
as calibrator. Results were analyzed using Sigmaplot 12.5
(Systat, Chicago, IL), and ANOVA was performed to
measure statistical differences between groups. Differ-
ences were considered statistically significant at P ≤ 0.05.
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